NEW YORK — Smiths Detection said on Wednesday that it has partnered with Attomarker on the development and manufacture of a SARS-CoV-2 antibody testing device.
UK-based Attomarker was spun out of the University of Exeter to develop a handheld device that works with a smartphone to rapidly measure blood biomarkers for liver disease and food allergens, as well as C-reactive protein. The company has also developed a test designed to detect immunoglobulin M, G, and A antibodies against SARS-CoV-2.